--2025/Q1-- / 762.000K--
--2024/Q4-- / 844.110K--
--2024/Q32.172M / 576.440K--
--2024/Q21.863M / 322.750K--
--2024/Q1874.000K / 371.400K--
US Stock MarketDetailed Quotes
DNTH Dianthus Therapeutics
- 22.340
- +2.070+10.21%
Close Nov 22 16:00 ET
- 22.340
- 0.0000.00%
Post 16:07 ET
661.20MMarket Cap-9776P/E (TTM)
22.390High20.370Low283.43KVolume20.370Open20.270Pre Close6.17MTurnover2.03%Turnover RatioLossP/E (Static)29.60MShares33.77052wk High1.96P/B312.45MFloat Cap6.58052wk Low--Dividend TTM13.99MShs Float336.000Historical High--Div YieldTTM9.97%Amplitude5.136Historical Low21.762Avg Price1Lot Size
Dianthus Therapeutics Key Stats
Dianthus Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Dianthus Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
